Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.01

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, versus $0.01 reported last year. Revenue for the quarter came in at $8.8 million, versus $7.9 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• RedHill Biopharma closes $6M private placement with warrant upside